"name","id","text","description","instanceType","label","uuid:ID"
"OBJ1","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Main objective","Objective","","4ce64f0d-a1be-4871-8e66-bdb349d30527"
"OBJ2","Objective_2","To document the safety profile of the xanomeline TTS.","Safety","Objective","","719546f4-4372-40a6-a2de-dbed4ed9eb58"
"OBJ3","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Behaviour","Objective","","f9168236-4e7d-4b22-b974-b651ad6ac698"
